Related Experiment Video
Updated: Jul 5, 2026

08:39
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Do graft type or donor source affect acute rejection rates after liver transplant: a multivariate analysis
Thanh H K Nguyen1, Keith Melancon, John Lake
1Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
Clinical Transplantation
|May 8, 2008
Summary
Graft type and donor source did not significantly impact acute rejection rates in adult liver transplants. Induction therapy, however, was associated with a reduced risk of acute rejection.
Area of Science:
- Hepatology
- Transplant Surgery
- Immunology
Background:
- Acute rejection (AR) is a significant complication following liver transplantation.
- Understanding factors influencing AR risk is crucial for improving patient outcomes.
- Graft type (whole vs. partial liver) and donor source (living vs. deceased donor) are potential determinants of AR.
Purpose of the Study:
- To investigate the influence of graft type and donor source on acute rejection rates in adult liver transplant recipients.
- To identify factors associated with an increased risk of acute rejection post-liver transplant.
Main Methods:
- Retrospective analysis of 292 deceased donor whole liver (DD-WL) transplants and 91 partial liver transplants (59 living donor liver transplants [LDLT] and 32 deceased donor split liver [DD-SL]) between 1999 and 2005.
- Comparison of AR rates at 12 months post-transplant across different graft types and donor sources.
- Multivariate analysis to identify independent predictors of AR, including the use of induction therapy.
Main Results:
- AR rates at 12 months were 10.0% for LDLT, 12.8% for DD-SL, and 16.5% for DD-WL.
- No statistically significant differences in AR rates were observed between LDLT, DD-SL, and DD-WL groups.
- Multivariate analysis revealed that neither graft type nor donor source impacted AR risk.
- The absence of induction therapy was the only factor significantly associated with an increased risk of AR.
Conclusions:
- Graft type and donor source do not appear to be significant predictors of acute rejection in adult liver transplantation.
- The use of induction therapy is a critical factor in mitigating the risk of acute rejection.
- Further research may explore optimal immunosuppression strategies based on graft characteristics and donor source.
Related Concept Videos
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

